Crowdstrike Explodes Into the Market
CrowdStrike entered the market with a bang. The stock was expected to price in the range of $28 to $30, but actually priced at $34 apiece.
All Work
Chris Lange
What to Expect When Lululemon Reports After the Close
Lululemon Athletica is scheduled to release its fiscal first-quarter financial results after the markets close on Wednesday.
Blue Apron Adds Another Executive to the Sinking Ship
Blue Apron Holdings shares have been absolutely devastated since the company came public in the summer of 2017. It seems that the company has tried everything to right the boat, and now it is…
Short Sellers Raise Their Bets in Cannabis Stocks
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Big Biotechs Have Short Sellers on the Run
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The May 31 short interest data have been compared with the previous report, and short interest in most of these…
Big Pharma Sees a Rising Tide in Short Interest
The May 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Does Semiconductor Short Interest Signal a Return to Market Highs?
The May 31 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks decreased.
No Fun For Dave & Buster’s Investors After Earnings
Dave & Buster’s Entertainment released its fiscal first quarter financial results after the markets closed on Tuesday.
What to Expect When Dave & Buster’s Reports After the Close
Dave & Buster’s is scheduled to release its most recent quarterly results after the markets close on Tuesday.
Amazon’s One-Two Punch Against Homelessness
Amazon shares were up slightly on Tuesday after the firm announced that it has made in-kind and cash donations to its Seattle nonprofit partners Mary’s Place and FareStart.
Meet the Newest Treatment for Autism Using Cannabidiol
Zynerba Pharma has just announced that the U.S. Patent and Trademark Office has issued a patent for the firm’s treatment of autism spectrum disorder with cannabidiol.
Is CymaBay Therapeutics’ Liver Disease Trial Sunk?
CymaBay Therapeutics shares were nearly halved early Tuesday after the company provided an update from its midstage study of seladelpar for the treatment of nonalcoholic steatohepatitis.
Why NovaBay Pharma Shares Absolutely Exploded
NovaBay shares absolutely exploded on Monday after the company announced that its eye care treatment would be readily available on Amazon.
Meet Salesforce’s Newest Acquisition
Salesforce shares dipped on Monday after the firm announced that it will acquire Tableau Software in an all-stock transaction. The transaction has been approved by the boards of directors of both companies.
Why Tilray Shares Are Lighting Up
Tilray shares jumped on Monday after the firm announced that it had signed a letter of intent with its largest stockholder Privateer Holdings.
How ReWalk Is Capitalizing on Its Big Win
ReWalkshares took a step back on Monday after the firm announced that it would be pricing a registered direct offering for $5 million. This comes after the stock had a phenomenal week when the…
Is GameStop Saying It’s Game Over With This Buyback?
GameStop shares jumped early on Monday after the video game retailer announced its intention to launch a modified Dutch auction tender offer.
Ascena Retail, H&R Block, Broadcom and More Earnings Coming This Week
24/7 Wall St. has put together a preview of Broadcom, H&R Block, Lululemon Athletica and some of the other most anticipated earnings reports expected this week.
How Zoom Knocked It Out of the Park With Q1 Earnings
Zoom Video stock soared on Friday after it released its fiscal first-quarter financial results late on Thursday.
What Analysts Are Saying About Beyond Meat After Earnings
Beyond Meat continued its meteoric rise on Friday after the firm reported its most recent quarterly results after markets closed Thursday. Analysts were quick to weigh in afterward.